Literature DB >> 33492668

Helically and Linearly Fused Rylenediimide-Hexabenzocoronenes.

Carolin Dusold1, Philipp Haines2, Benedikt Platzer2, Dirk M Guldi2, Andreas Hirsch1.   

Abstract

Perylene- as well as naphthalenediimides were fused to hexabenzocoronenes (HBCs) at their imide position to realize highly π-extended donor-acceptor (D-A)-hybrids. Successful isomer separation in the first step was decisive to guarantee a straightforward synthetic sequence. Hexaphenylbenzenes as precursors were accessed via Diels-Alder reactions and reacted in a Scholl oxidation to yield the respective HBC derivatives. The fully conjugated benzimidazole linker, which separates the electron donating HBC from the electron accepting rylenediimide, enabled the formation of either a linear or a helical configuration. Largely different chemical, physical, and optoelectrical characteristics were noted for the two configurations. What stood out was their aggregation and their excited state deactivation depending on the solvent polarity. Results from global analysis of the femtosecond transient absorption data corroborated the formation of a charge-transfer (CT) state that is stabilized in the helically fused configuration relative to the linear analogue. However, a comparison with spectroelectrochemical experiments failed to disclose evidence for a charge-separated (CS) state.
© 2021 The Authors. Chemistry - A European Journal published by Wiley-VCH GmbH.

Entities:  

Keywords:  charge transfer; helicene; hexabenzocoronene HBC; rylenediimide; transient absorption

Year:  2021        PMID: 33492668     DOI: 10.1002/chem.202005235

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  1 in total

Review 1.  Recent Advances in Heterocyclic Nanographenes and Other Polycyclic Heteroaromatic Compounds.

Authors:  Arseni Borissov; Yogesh Kumar Maurya; Liliia Moshniaha; Wai-Shing Wong; Marika Żyła-Karwowska; Marcin Stępień
Journal:  Chem Rev       Date:  2021-12-01       Impact factor: 60.622

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.